Nome Químico: (4S)-6-Chloro-4-(cyclopropylethynyl)-2-(4-methoxyphenyl)-4-(trifluoromethyl)-1,4-dihydro-2H-benzo[d][1,3]oxazine
Sorrisos: FC(F)(F)[C@@]1(C2=CC(Cl)=CC=C2NC(C3=CC=C(OC)C=C3)O1)C#CC4CC4
Inchi: InChI=1S/C26H27Cl2NO/c1-3-29(4-2)17-18-30-25-15-9-22(10-16-25)26(21-7-13-24(28)14-8-21)19-20-5-11-23(27)12-6-20/h5-16,19H,3-4,17-18H2,1-2H3/b26-19+
Development and validation of a HPLC analytical assay method for efavirenz tablets: a medicine for HIV infections
Osnir de Sá Viana1 , Flávia Patrícia Morais Medeiros2 , Severino Grangeiro-Júnior2 , Miracy Muniz Albuquerque1 , Mônica Felts La Roca Soares1-3, José Lamartine Soares-Sobrinho1-3, Lariza Darlene Santos Alves1 , Larissa Araújo Rolim1 , Keyla Emanuelle Ramos da Silva1 , Pedro José Rolim-Neto
Braz. J. Pharm. Sci. vol.47 no.1 São Paulo Jan./Mar. 2011
Investigation of the solvent-dependent photolysis of a nonnucleoside reverse-transcriptase inhibitor, antiviral agent efavirenz
Maryam A Jordaan and Michael Shapi
Antiviral Chemistry and Chemotherapy 2017: 1–11
Method Development and Validation for Related Impurities of Efavirenz by RP-HPLC Method
Desaraju Bhargavi, Bhukya Babu Rao, Gangarapu Kiran, Thumma Gouthami & Vasudha Bakshi
TACL 7 (5) 2017 pp 737 – 747